ResMed Story Overview

RMD -- USA Stock  

USD 113.83  2.04  1.82%

Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance.
Payment of 4027 shares by Don Darkin of ResMed subject to Rule 16b-3
Filed transaction by Resmed Inc officer. Payment of exercise price or tax liability by delivering or withholding securities

ResMed Inc insider trading alert for payment of resmed common stock by Don Darkin, Pres. SDB SBU, on January 3, 2018. This event was filed by Resmed Inc with SEC on 2012-11-13. SEC Form: Changes in beneficial ownership. Don Darkin is currently serves as president - sleep-disordered breathing strategic business unit of ResMed Inc

Story Momentum

This article from MacroaxisInsider published on 03 of January contributed to the next trading period price escalation.The trading delta at closing time to the next next day price was 0.14% . The trading delta at closing time when the story was published to current price is 31.53% .

Similar stores for ResMed

a day ago at www.macroaxis.com 
Acquisition by David Pendarvis of 5168 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
few days ago at www.macroaxis.com 
Sale by Brett Sandercock of 2000 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over a week ago at http://www.mareainformativa.com 
US Bancorp DE Reduces Position in ResMed Inc.
news
Marea Informative Full coverage
over a week ago at http://www.fool.com.au 
How Im preparing for the next financial crisis
fool News
Motley Fool AustraliaFull coverage
over two weeks ago at www.macroaxis.com 
Sale by Hollingshead James of 600 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over three weeks ago at http://www.wallstreetinvestorplace.com 
Low-Risky stock to Watch ResMed Inc.
news
Wallstreet InvestorplaceFull coverage
over three weeks ago at www.macroaxis.com 
Sale by Brett Sandercock of 2000 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
over a month ago at http://cedarvillenews.com 
Putting ResMed Inc Under the Microscope Stock Ticks -0.13
news
Cedarville NewsFull coverage
over a month ago at www.macroaxis.com 
Acquisition by Richard McHale of 7296 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at http://simplywall.st 
What Should You Know About ResMed Incs Future
news
Simply Wall StHodges Capital Management Trimmed Its Gogo Position Bank Of Nova Scotia Has Trimmed Resmed Long or Short ResMed TNNFull coverage
over a month ago at www.macroaxis.com 
Exercise or conversion by David Pendarvis of 2810 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over two months ago at http://carthagestandard.com 
What Kind of Picture Are the Technicals Painting For ResMed Inc Shares Tick -0.21
news
Carthage StandardWhy ResMed Inc. Is Being Added to Investors Watchlist StockNewsGazetteFull coverage
over three months ago at http://danversrecord.com 
Resmed Inc Heading in the Right Direction
news
Danvers RecordFull coverage

Operating Margin

Operating Margin Comparative Analysis

  Operating Margin 
      ResMed Comparables 
ResMed is rated below average in operating margin category among related companies. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Peers

ResMed Related Equities

CO  2.51 %   
0%
100.0%
RMD  1.82 %   
0%
72.0%
EW  1.46 %   
0%
58.0%
VAR  0.72 %   
0%
28.0%
A  0.58 %   
0%
23.0%
TFX  0.10 %   
0%
4.0%
XRAY  0.39 %   
15.0%
0%
CI  0.45 %   
17.0%
0%
SYK  0.88 %   
35.0%
0%
Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com